Skip to main content

Outbreak of West Nile Virus May Be Worst Ever


August 22, 2012 — An outbreak of West Nile virus infections that has claimed more than 3 dozen lives this year could shape up to be worst ever, the US Centers for Disease Control and Prevention (CDC) announced today.
The number of reported cases jumped in just a week's time from 693, as of August 14, to 1118, as of August 21, according to the agency. During that same period, the number of reported deaths rose from 26 to 41.
"We're in the midst of one of the largest outbreaks of West Nile virus ever seen," said Lyle Petersen, MD, MPH, director of the CDC's Division of Vector-Borne Infectious Diseases, in a press briefing today. The number of disease cases reported in 2012 through August 21 is the highest for this time frame since the mosquito-borne virus was first detected in the United States in 1999.
West Nile virus infections typically peak in mid-August, but the CDC expects the case count to continue rising through the end of September because of delays in the cases getting reported, said Dr. Petersen. "It takes a couple of weeks for [an infected] person to get sick, go to the doctor, and get reported."
If the case count stays on its current trajectory through year's end, he said, "this will be among the biggest or the biggest outbreak."
Texas is the epicenter of the outbreak, with 537 reported cases and 19 deaths — nearly half of the nationwide totals. Last week the mayor of hard-hit Dallas declared a state of emergency as a prelude to aerial spraying of insecticide to kill off mosquitos. The only states not to report West Nile virus infections so far are Alaska, Hawaii, and Vermont.
Dr. Petersen said it is not clear why 2012 is a bad year for the West Nile virus, but the heat wave that has scorched much of the country is a likely suspect.
"One observation that has occurred in the United States and elsewhere is that hot weather seems to promote West Nile virus outbreaks," he said. Lab experiments show that higher temperatures increase the transmissibility of the virus through mosquitos.
Fever Cases "Very Underreported"
For the 1118 cases of West Nile virus infection reported through August 21, roughly 44% of patients had fever while the rest contracted neuroinvasive diseases — in particular, encephalitis and meningitis. The death rate for infected individuals with neuroinvasive diseases is 10%. Survivors often struggle with neurological or cognitive problems for years.
The proportion of reported cases with neuroinvasive diseases is misleading because the fever cases "are very underreported," Dr. Petersen said. Only 1 in 150 individuals infected with the virus develop a neuroinvasive disease, but almost all of them end up in the hospital. In contrast, up to 20% of infected individuals experience fever and other symptoms considered milder than neuroinvasive disease, but many of them never bother to consult a clinician. When they do, clinicians may not diagnose a West Nile virus infection. In addition, the CDC does not recommend routine testing for infections presenting with fever.
"The most important data we have is for neuroinvasive-disease cases," Dr. Petersen said. "We do believe they're reasonably reported."
The remaining 80% of individuals who acquire the virus experience no symptoms whatsoever.
So far, public health authorities can battle the outbreak only by spraying mosquitos with insecticide and reminding Americans to take precautions such as using insect repellent and emptying standing water from outdoor buckets and similar places where mosquitos might breed. There is no vaccine against the virus, nor any treatment, other than supportive measures such as hospitalization, intravenous fluids, respiratory support, and prevention of secondary infections for those with more severe forms of the viral infection, according to the CDC.

Comments

Post a Comment

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...
Post a Comment
Read more

FDA Decision Delayed for Truvada in HIV PrEP

June 11, 2012 — The US Food and Drug Administration (FDA) has delayed its decision on allowing the use of tenofovir disoproxil fumarate/emtricitabine ( Truvada , Gilead) as preexposure prophylaxis (PrEP) so that the proposed risk evaluation and mitigation strategy (REMS) can be reviewed. In early May, the FDA's Antiviral Drugs Advisory Committee  strongly backed  approval of the first-ever drug for the prevention of sexually acquired HIV-1 infection. However, concerns by the panel at the time included that people may neglect condom use if they feel they are protected by PrEP. Panelists were also concerned that uninfected people taking PrEP who become infected with HIV may not switch to a 3-drug regimen as recommended. According to the company, the FDA has postponed the target date to September 14 so it can review Gilead's REMS plan to help ensure that patients will not misuse the drug. The committee's recommendation for supplemental approval of tenofovir/emtricit...
Post a Comment
Read more

Antidepressants Linked to Higher Diabetes Risk in Kids

Pediatric patients who use antidepressants may have an elevated risk for type 2 diabetes, the authors of a new study report. In a retrospective cohort study of more than 119,000 youths 5 to 20 years of age, the risk for incident type 2 diabetes was nearly twice as high among current users of certain types of antidepressants as among former users, Mehmet Burcu, PhD, and colleagues report in an article  published online October 16 in  JAMA Pediatrics . The risk intensified with increasing duration of use, greater cumulative doses, and higher daily doses of these antidepressants. The findings point to a growing need for closer monitoring of these products, including greater balancing of risks and benefits, in the pediatric population, the authors caution. They undertook the study because, despite growing evidence of an association between antidepressant use and an increased risk for type 2 diabetes in adults, similar research in pediatric patients was scarce. "To our know...
Post a Comment
Read more